Filing Details
VivoSim Labs, INC. (NASDAQ:VIVS) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 14, 2026.
The Healthcare company's annual report covers fiscal year 2026.
10k filedNASDAQ:VIVS
VivoSim Labs, INC. (VIVS) Files Annual Report with SEC
Filing Details VivoSim Labs, INC. (NASDAQ:VIVS) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 14, 2026. The Healthcare company's annual…
Market Context
VivoSim Labs, INC.'s stock currently trades at $0.83 with a market capitalization of $5.8M.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For VivoSim Labs, INC. investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for VivoSim Labs, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VIVS Stock Page
Frequently Asked Questions
Where can I read VIVS's SEC filings?
Browse all filings on our VIVS SEC filings page.
What types of SEC filings does VivoSim Labs, INC. file?
Public companies like VivoSim Labs, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.